Long‐term follow‐up results of the Pacing to Avoid Cardiac Enlargement (PACE) trial
- 1 September 2014
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 16 (9), 1016-1025
- https://doi.org/10.1002/ejhf.157
Abstract
Aims We report the results of long‐term follow‐up of the Pacing to Avoid Cardiac Enlargement (PACE) trial, a prospective, double‐blinded, randomized, multicentre study that confirmed the superiority of biventricular (BiV) pacing compared with right ventricular apical (RVA) pacing in prevention of LV adverse remodelling and deterioration of systolic function at 1 and 2 years. Methods and results Patients with bradycardia and preserved LVEF were randomized to receive RVA (n = 88) or BiV pacing (n = 89). Co‐primary endpoints were LV end‐systolic volume (LVESV) and LVEF measured by echocardiography. There were 149 patients who had extended follow‐up, with a mean duration of 4.8 ± 1.5 years (2.5–7.8 years). The primary endpoint analyses were performed in 146 patients (74 in the RVA group and 72 in the BiV group). In the RVA pacing group, the LVEF decreased while the LVESV increased progressively at follow‐up, but remained unchanged in the BiV pacing group. The differences in LVEF between the RVA and BiV groups were –6.3, –9.2, and –10.7% at 1‐year, 2‐year, and long‐term follow‐up, respectively (all P < 0.001). The corresponding differences in LVESV were +7.4, +9.9, and +13.1 mL, respectively (all P < 0.001). The deleterious effects of RVA pacing consistently occurred in all the pre‐defined subgroups. Furthermore, patients with RVA pacing had a significantly higher prevalence of heart failure hospitalization than the BiV group (23.9% vs. 14.6%, log‐rank χ2 = 7.55, P = 0.006). Conclusion Left ventricular adverse remodelling and deterioration of systolic function continued at long‐term follow‐up in patients with RVA pacing; this deterioration was prevented by the use of BiV pacing. Also, heart failure hospitalization was more prevalent in the RVA pacing group. Trial registration CUHK_CCT00037.Funding Information
- This study was supported by a research grant from Medtronic Inc. (Nil)
This publication has 33 references indexed in Scilit:
- Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trialEuropean Heart Journal, 2011
- Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillatorHeart Rhythm, 2011
- Effect of Pacing for Soft Indications on Mortality and Heart Failure in the Dual Chamber and VVI Implantable Defibrillator (DAVID) TrialPacing and Clinical Electrophysiology, 2008
- Percent right ventricular pacing predicts outcomes in the DAVID trialHeart Rhythm, 2005
- A randomized comparison ofatrial and dual-chamber pacing in177 consecutive patients with sick sinus syndrome: Echocardiographic and clinical outcomeJournal of the American College of Cardiology, 2003
- Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node DysfunctionCirculation, 2003
- Dual-Chamber Pacing or Ventricular Backup Pacing in Patients With an Implantable DefibrillatorJAMA, 2002
- Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node DysfunctionThe New England Journal of Medicine, 2002
- Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndromeThe Lancet, 1997
- Asymmetric thickness of the left ventricular wall resulting from asynchronous electric activation: A study in dogs with ventricular pacing and in patients with left bundle branch blockAmerican Heart Journal, 1995